Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012

Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012" provides data on the Retinitis Pigmentosa (Retinitis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinitis Pigmentosa (Retinitis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinitis Pigmentosa (Retinitis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Contents

Introduction
Retinitis Pigmentosa (Retinitis)
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Retinitis Pigmentosa (Retinitis)
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Neurotech Pharmaceuticals, Inc.
Clinical Trial Overview of Neurotech Pharmaceuticals, Inc.
R-Tech Ueno, Ltd.
Clinical Trial Overview of R-Tech Ueno, Ltd.
Okuvision GmbH
Clinical Trial Overview of Okuvision GmbH
Sucampo Pharmaceuticals, Inc.
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Daewoong Pharmaceutical Co., Ltd.
Clinical Trial Overview of Daewoong Pharmaceutical Co., Ltd.
Oxford BioMedica plc
Clinical Trial Overview of Oxford BioMedica plc
Isis Pharmaceuticals, Inc.
Clinical Trial Overview of Isis Pharmaceuticals, Inc.
Allergan, Inc.
Clinical Trial Overview of Allergan, Inc.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Neurovision Research Institute
Clinical Trial Overview of National Neurovision Research Institute
Third Military Medical University
Clinical Trial Overview of Third Military Medical University
Kyushu University
Clinical Trial Overview of Kyushu University
Chiba University Hospital
Clinical Trial Overview of Chiba University Hospital
Nagoya City University Hospital
Clinical Trial Overview of Nagoya City University Hospital
Institute of Biomedical Research and Innovation Hospital
Clinical Trial Overview of Institute of Biomedical Research and Innovation Hospital
Montpellier University Hospital
Clinical Trial Overview of Montpellier University Hospital
Azienda Policlinico Umberto I
Clinical Trial Overview of Azienda Policlinico Umberto I
Tokyo Women's Medical University
Clinical Trial Overview of Tokyo Women's Medical University
Tehran University of Medical Sciences
Clinical Trial Overview of Tehran University of Medical Sciences
Semmelweis University
Clinical Trial Overview of Semmelweis University
Chiba University
Clinical Trial Overview of Chiba University
Osaka University
Clinical Trial Overview of Osaka University
Indian Council of Medical Research
Clinical Trial Overview of Indian Council of Medical Research
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
Columbia University
Clinical Trial Overview of Columbia University
University of Sao Paulo
Clinical Trial Overview of University of Sao Paulo
Sheba Medical Center
Clinical Trial Overview of Sheba Medical Center
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, North America, Top Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, BRIC Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, G7 Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, E7 Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurotech Pharmaceuticals, Inc., 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by R-Tech Ueno, Ltd., 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Okuvision GmbH, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daewoong Pharmaceutical Co., Ltd., 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oxford BioMedica plc, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Neurovision Research Institute, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University Hospital, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya City University Hospital, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Policlinico Umberto I, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Women's Medical University, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Semmelweis University, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012*

LIST OF FIGURES

Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, G7 Countries (%), 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, E7 Countries (%), 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top